openPR Logo
Press release

Multi-Kinase Treatment Market is Driven by the Increasing Occurrence of Cancer Across the Globe

05-23-2017 03:54 PM CET | Health & Medicine

Press release from: TMR - Research Reports

Multi-Kinase Treatment Market is Driven by the Increasing

Global Multi-Kinase Treatment Market: Overview

Unwanted gene variations on a daily basis may lead to cancer, wherein the body goes on immoderate replication of cells (tumor). With the rising prevalence of cancer, the demand for multi-kinase treatment is all set to rise exponentially. A protein kinase inhibitor controls or blocks the action of one or more protein kinases by adding a phosphate group (PO4) to a protein. Since in the majority tumors, multiple signaling pathways are involved, a large number of inhibitors in clinical development are formulated to impact a wide range of targeted kinases. Multi-kinase treatments are preferred to single target treatments as they are more effective in combating multi-factorial diseases and are needed to circumvent difficulties such as the development of resistance. The advantages and disadvantages of these treatments are gauged on the basis of pharmacokinetics, resistance mechanisms, tumor environment, and selectivity.

Browse through Multi-Kinase Treatment Market report to know what factors will shape the market by 2024: http://www.transparencymarketresearch.com/multikinase-treatment-market.html

The report offers a comprehensive overview of the multi-kinase industry through important classifications, product definitions, and participants in the industry chain structure. It has been compiled considering and methodically examining multiple facets of the market, including but not limited to trends and opportunities, import and export details, regional markets, and competitive landscape.

Global Multi-Kinase Treatment Market: Drivers and Restraints

The global multi-kinase treatment market is primarily driven by the increasing occurrence of cancer across the globe. The rapidly growing population and changing lifestyles are contributing to the mounting cases of cancer. The majority of multi-kinase inhibitors are used for advanced cancer conditions such as lung cancer, leukemia, prostate cancer, colorectal cancer, and renal cancer. Since cancer is still incurable in its advanced stages, the possibility of extending the lifespan of patients by at least a year or more is readily accepted by most of the cancer patients. In recent times, the improving healthcare infrastructure is emerging instrumental in providing significant momentum to the global market.

On the flip side, the rising awareness about the side effects of multi-kinase treatment is restraining the growth of the market. These treatments are harmful to the normal functioning of the liver and critical organs such as lungs and kidneys. To mitigate their side effects, these inhibitors are accompanied by other regulators and antibiotics, which might also have negative effects on the liver. However, many recent advances in cancer therapy are ensuring increased efficiency and minimized off-target and systemic side effects.

Global Multi-Kinase Treatment Market: Regional Outlook

On the basis of geography, the global multi-kinase treatment market is segmented into Asia Pacific, Europe, North America, and Rest of the World. North America is the leading regional market in terms of volume, with the U.S. being a major contributor. The presence of government subsidies is adversely affecting the overall revenue generation in Asia Pacific; nevertheless, the region is estimated to rise at a significant CAGR during the forecast period owing to the presence of immense untapped opportunities. Europe and Rest of the World are expected to expand at a steady pace over the same period.

Get accurate market forecast and analysis on the Multi-Kinase Treatment Market. Request a sample to stay abreast on the key trends impacting this market: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=7493

Companies Mentioned in the Report:

The overall market for multi-kinase treatment remains positive as recent developments and innovations by the leading players in this field have already recorded more than 85% success rate. Some of the key players in the market are AstraZeneca plc, Bristol-Myers Squibb Company, C. H. Boehringer Sohn AG & Co. KG, Genentech Inc., Pfizer Inc., GlaxoSmithKline plc, and Novartis International AG.

Transparency Market Research (TMR) is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Multi-Kinase Treatment Market is Driven by the Increasing Occurrence of Cancer Across the Globe here

News-ID: 547727 • Views:

More Releases from TMR - Research Reports

Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2024
Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during
North America Ventricular Assist Device Market is rising to a valuation of US$ 1.07 Billion by 2024
North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million by 2024
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016. The global dental membrane and bone graft substitutes market is expected to
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period. By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment

All 5 Releases


More Releases for Treatment

Medical Tourism Market Report by Treatment Type (Dental Treatment, Cosmetic Trea …
The global medical tourism market accounted for $104.68 billion in 2019, and is projected to reach $273.72 billion by 2027, registering a CAGR of 12.8% from 2019 to 2027 in terms of value. View Full Report: https://reports.valuates.com/market-reports/ALLI-Auto-0P310/medical-tourism In terms of volume, the global medical tourism market accounted for 23,042.90 thousand patients in 2019, and is projected to reach 70,358.61 thousand patients by 2027, registering a CAGR of 15.0% from 2019 to
Stretch Marks Treatment Market by Treatment & Forecast - 2025
Global Stretch Marks Treatment Market: Snapshot In order to expand their outreach and add to their product portfolio, keen players in the global stretch marks treatment market are taking the inorganic route of acquisitions. They are also pouring money into development of new and better products. Rising instances of obesity causing stretch marks is serving to catalyze growth in the market. In addition, growing aesthetic consciousness among people, especially among pregnant women,
Medical Tourism Market by Treatment Type (Dental Treatment, Cosmetic Treatment, …
Medical Tourism Market Overview: The global medical tourism market was valued at $53,768 million in 2017, and is estimated to reach at $143,461 million by 2025, registering a CAGR of 12.9% from 2018 to 2025. Organized travel across international borders to avail medical treatment of some form, which may or may not be available in the travelers home country is defined as medical tourism. Medical tourists travel abroad for the maintenance, enhancement,
Substance Use Disorder Treatment Market By Type (Alcohol abuse treatment, Nicoti …
According to World Health Organization (WHO), the leading cause of disability around the world is not a physical disease, but a serious mood disorder known as depression. Around 350 million people suffer from depression worldwide, and that only about 50% of these individuals will ever receive treatment. According to Anxiety and Depression Association of America, in the U.S., over 15 million adults experience an episode of clinical depression in any
Health Tourism Market Global Industry Analysis, By Key Players, Segmentation, Tr …
Huge increase in demand and new phenomenon in the healthcare industry known as health tourism. It is one of the fastest growing industry and economic growth areas globally, as people today demanding for better quality, faster and cheaper alternatives of healthcare offered in their own countries. Health tourism is also known as medical travel or global health care, defined as the act of travelling to foreign countries with purpose of
Addiction Treatment Market: Tobacco/Nicotine Addiction Treatment Dominates the M …
Transparency Market Research (TMR) has published a new report titled “Addiction Treatment Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017–2025”. According to the report, the global addiction treatment market was valued at approximately US$ 4.0 Bn in 2016 is projected to expand at a CAGR of over 6.0% from 2017 to 2025. The report suggests that growing abuse of prescription drugs and favorable reimbursements for smoking